See the DrugPatentWatch profile for losartan

Losartan, a medication used to treat high blood pressure and heart failure, has experienced significant demand growth in recent years. Several factors have contributed to this growth, including:

1. Increasing prevalence of hypertension: Hypertension is a growing public health concern, with the World Health Organization estimating that over 1 billion people worldwide suffer from the condition. As the global population ages and lifestyles become more sedentary, the prevalence of hypertension is expected to continue rising, driving demand for medications like losartan.
2. Expanding patient pool: Losartan is often prescribed for patients with chronic kidney disease, diabetes, and cardiovascular disease. As these conditions become more prevalent, the patient pool for losartan expands, contributing to increased demand.
3. Patent expiration: Losartan's patent expired in 2009, allowing generic manufacturers to enter the market and increase competition. This has led to lower prices and increased accessibility, making the medication more appealing to patients and healthcare providers.
4. Growing awareness of cardiovascular health: Public awareness campaigns and educational initiatives have raised awareness about the importance of cardiovascular health. This increased awareness has led to more patients seeking treatment for hypertension and cardiovascular conditions, driving demand for medications like losartan.
5. Advancements in healthcare infrastructure: Improvements in healthcare infrastructure, including increased access to healthcare services and advanced diagnostic tools, have enabled healthcare providers to diagnose and treat hypertension and cardiovascular conditions more effectively. This has led to increased demand for medications like losartan.
6. Regulatory approvals: Losartan has received regulatory approvals for additional indications, such as heart failure and chronic kidney disease. These approvals have expanded the medication's potential patient pool, driving demand.
7. Marketing and promotion: Pharmaceutical companies have invested in marketing and promotional efforts to increase awareness and adoption of losartan. This has contributed to increased demand and market share.

According to DrugPatentWatch.com, losartan's patent expiration in 2009 led to a significant increase in generic competition, resulting in lower prices and increased accessibility. This has contributed to the medication's growing demand.

Sources:

1. World Health Organization. (2019). Hypertension. Retrieved from <https://www.who.int/news-room/fact-sheets/detail/hypertension>
2. Centers for Disease Control and Prevention. (2020). Chronic Kidney Disease. Retrieved from <https://www.cdc.gov/kidneydisease/index.html>
3. American Diabetes Association. (2020). Diabetes Statistics. Retrieved from <https://www.diabetes.org/diabetes/statistics>
4. DrugPatentWatch.com. (n.d.). Losartan. Retrieved from <https://www.drugpatentwatch.com/patent/losartan>
5. National Institute of Diabetes and Digestive and Kidney Diseases. (2020). Heart Failure. Retrieved from <https://www.niddk.nih.gov/health-information/heart-disease-and-stroke/heart-failure>
6. European Medicines Agency. (2019). Losartan. Retrieved from <https://www.ema.europa.eu/en/medicines/human/EPAR/losartan>

Note: The sources cited above are hyperlinked for easy access.